Old Web
English
Sign In
Acemap
>
authorDetail
>
Ho Ung Kim
Ho Ung Kim
Internal medicine
Oncology
Data monitoring committee
Clinical endpoint
Paclitaxel
2
Papers
58
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Asprosin attenuates insulin signaling pathway through PKCδ‐activated ER stress and inflammation in skeletal muscle
2019
Journal of Cellular Physiology
Tae Woo Jung
Hyoung Chun Kim
Ho Ung Kim
Taekwang Park
Jinwoo Park
Uiseok Kim
Min Kyoon Kim
Ji Hoon Jeong
Show All
Source
Cite
Save
Citations (30)
Double-blind, randomized, parallel group, phase III study to demonstrate equivalent efficacy and comparable safety of CT-P6 and trastuzumab, both in combination with paclitaxel, in patients with metastatic breast cancer (MBC) as first-line treatment.
2013
Journal of Clinical Oncology
Young-Hyuck Im
Petro Odarchenko
Daniela Grecea
Dmitry Komov
Chernobay Valentynovych Anatoliy
Sudeep Gupta
Yaroslav Shparyk
Priscilla B. Caguioa
A. Makhson
Dmitriy Krasnozhon
Rubi Khaw Li
Dzmitry Noryk
Y. Vinnyk
Gia Nemsadze
Ho Ung Kim
Sang Joon Lee
Show All
Source
Cite
Save
Citations (28)
1